Atlas Trials

Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

Clinical trial NCT07776522 · RECRUITING

Trial details

NCT number
NCT07776522
Sponsor
West China Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Start date
2026-08-31
Primary completion
2027-08-15
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.